Taylor Stacy L
SEC CIK 1799081 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ADPT | Adaptive Biotechnologies Corp | SVP, GC | 139.4K | — | $1.03M | 14 | 2021-06-30 | 2024-08-22 |
Most active insiders at ADPT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | ROBINS CHAD M | CEO, COB, Dir | — | $39.80M |
| 2 | ROBINS HARLAN S | CSO | — | $29.65M |
| 3 | BENZENO SHARON | Chief Commercial Ofc Imm Med | — | $14.69M |
| 4 | RUBINSTEIN JULIE | Pres, COO | — | $13.37M |
| 5 | LO FRANCIS | CHRO | — | $13.21M |
| 6 | PISKEL KYLE | CFO | — | $3.58M |
| 7 | NEUPERT PETER M | Dir | — | $3.14M |
| 8 | GRIFFIN MICHELLE RENEE | Dir | — | $2.00M |
| 9 | BOBULSKY SUSAN | Chief Commercial Off, MRD | — | $1.20M |
| 10 | HERSHBERG ROBERT | Dir | — | $1.12M |
Taylor Stacy L made no open-market trades at ADPT in the last 12 months.
Transactions 14
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-08-23 | 2024-08-22 | ADPT | Adaptive Biotechnologies Corp | Taylor Stacy L | SVP, GC | S - Sale | $4.50 | -26.9K | 139.4K | -16% | -$121.1K | |
| D | 2024-03-06 | 2024-03-04 | ADPT | Adaptive Biotechnologies Corp | Taylor Stacy L | SVP, GC | A - Grant | $0.00 | +40.0K | 179.7K | +29% | $0 |
| DM | 2024-03-06 | 2024-03-05 | ADPT | Adaptive Biotechnologies Corp | Taylor Stacy L | SVP, GC | S - Sale | $3.43 | -13.4K | 172.9K | -7% | -$46.0K |
| DM | 2023-03-08 | 2023-03-06+ | ADPT | Adaptive Biotechnologies Corp | Taylor Stacy L | SVP, GC | S - Sale | $8.59 | -18.9K | 153.1K | -11% | -$162.2K |
| D | 2023-03-08 | 2023-03-06 | ADPT | Adaptive Biotechnologies Corp | Taylor Stacy L | SVP, GC | A - Grant | $0.00 | +85.7K | 158.6K | +118% | $0 |
| 2022-03-10 | 2022-03-08 | ADPT | Adaptive Biotechnologies Corp | Taylor Stacy L | SVP, GC | S - Sale | $11.44 | -2,387 | 72.9K | -3% | -$27.3K | |
| D | 2022-03-08 | 2022-03-07 | ADPT | Adaptive Biotechnologies Corp | Taylor Stacy L | SVP, GC | S - Sale | $12.01 | -1,569 | 75.2K | -2% | -$18.8K |
| D | 2022-03-08 | 2022-03-04 | ADPT | Adaptive Biotechnologies Corp | Taylor Stacy L | SVP, GC | A - Grant | $0.00 | +61.8K | 76.8K | +411% | $0 |
| DM | 2021-12-23 | 2021-12-22 | ADPT | Adaptive Biotechnologies Corp | Taylor Stacy L | SVP, GC | M - OptEx | $6.97 | +15.3K | 25.2K | +156% | +$107.0K |
| D | 2021-12-23 | 2021-12-22 | ADPT | Adaptive Biotechnologies Corp | Taylor Stacy L | SVP, GC | S - Sale+OE | $30.00 | -15.3K | 15.0K | -50% | -$460.1K |
| D | 2021-09-09 | 2021-09-07 | ADPT | Adaptive Biotechnologies Corp | Taylor Stacy L | SVP, GC | M - OptEx | $6.55 | +495 | 15.5K | +3% | +$3,242 |
| D | 2021-09-09 | 2021-09-07 | ADPT | Adaptive Biotechnologies Corp | Taylor Stacy L | SVP, GC | S - Sale+OE | $40.00 | -495 | 15.0K | -3% | -$19.8K |
| DM | 2021-07-01 | 2021-06-30 | ADPT | Adaptive Biotechnologies Corp | Taylor Stacy L | SVP, GC | S - Sale+OE | $41.42 | -4,167 | 15.4K | -21% | -$172.6K |
| DM | 2021-07-01 | 2021-06-30 | ADPT | Adaptive Biotechnologies Corp | Taylor Stacy L | SVP, GC | M - OptEx | $15.04 | +4,167 | 19.2K | +28% | +$62.7K |
Purchase Sale Sale after option exercise All abbreviations